2020 POSTER Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor is an Effective Radiosensitizer for the Treatment of Colorectal Cancer

2011 ◽  
Vol 47 ◽  
pp. S194
Author(s):  
Y.H. Chen ◽  
S.H. Kuo ◽  
M.F. Wei ◽  
S.L. Pan ◽  
C.W. Wang ◽  
...  
2015 ◽  
Vol 357 (2) ◽  
pp. 582-590 ◽  
Author(s):  
Yu-Hsuan Chen ◽  
Ming-Feng Wei ◽  
Chun-Wei Wang ◽  
Hsiao-Wei Lee ◽  
Shiow-Lin Pan ◽  
...  

2009 ◽  
Vol 29 (5) ◽  
pp. 517-520
Author(s):  
Hong-gang XIANG ◽  
Zhi-qian HU ◽  
Wei-jun WANG ◽  
Jian XU ◽  
Jian ZHANG ◽  
...  

2020 ◽  
Vol 19 (2) ◽  
pp. 206-210
Author(s):  
Feng Chen ◽  
Bei Zhang

Lupeol exhibits multiple pharmacological activities including, anticancerous, anti-inflammatory, and antioxidant. The aim of this study was to explore the anticancerous activity of lupeol on ovarian cancer cells and examine its mechanism of action. To this end, increasing concentrations of lupeol on cell viability, cell cycle, and apoptosis in Caov-3 cells were evaluated. Lupeol inhibited cell viability, induced G1 phase arrest in cell cycle, increased cell apoptosis, and inhibited the ratio of phospho-Akt/protein kinase B and phospho-mammalian target of rapamycin/mammalian target of rapamycin. In conclusion, these data suggest that lupeol may play a therapeutic role in ovarian cancer.


2012 ◽  
Author(s):  
Venkat R. Katkoori ◽  
Sandeep Choudhary ◽  
Abraham R. Butler ◽  
Chandrakumar Shanmugam ◽  
Liselle L. Bovell ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document